Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine in a Basal-Bolus Regimen in Patients with Type 1 Diabetes Mellitus in the United Kingdom

Insulin Degludec ◽

The United Kingdom ◽

Cost-effectiveness of insulin degludec compared with insulin glargine in a basal-bolus regimen in patients with type 1 diabetes mellitus in the UK

Journal of Medical Economics ◽

10.3111/13696998.2014.971160 ◽

2014 ◽

Vol 18 (1) ◽

pp. 56-68 ◽

Cited By ~ 26

Author(s):

M. Evans ◽

M. Wolden ◽

J. Gundgaard ◽

B. Chubb ◽

T. Christensen

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Insulin Degludec ◽

The Uk ◽

Cost‐effectiveness of dapagliflozin as an adjunct to insulin for the treatment of type 1 diabetes mellitus in the United Kingdom

Diabetes Obesity and Metabolism ◽

10.1111/dom.13992 ◽

2020 ◽

Vol 22 (7) ◽

pp. 1047-1055 ◽

Cited By ~ 1

Author(s):

Hayley Bennett ◽

Amarjeet Tank ◽

Marc Evans ◽

Klas Bergenheim ◽

Phil McEwan

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

The United Kingdom

Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals

Journal of Clinical & Translational Endocrinology ◽

10.1016/j.jcte.2015.12.002 ◽

2016 ◽

Vol 3 ◽

pp. 14-20

Author(s):

Elizabeth Mary Lamos ◽

Lisa M. Younk ◽

Donna B. Tate ◽

Stephen N. Davis

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Pharmacokinetics And Pharmacodynamics ◽

Glargine Insulin ◽

Analog Insulin ◽

Insulin Glulisine ◽

Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus

Diabetes Therapy ◽

10.1007/s13300-013-0048-5 ◽

2013 ◽

Vol 4 (2) ◽

pp. 461-472 ◽

Cited By ~ 21

Author(s):

Yoshiki Kusunoki ◽

Tomoyuki Katsuno ◽

Kana Miyakoshi ◽

Takashi Ikawa ◽

Rie Nakae ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Insulin Degludec

COST ANALYSIS OF INSULIN DEGLUDEC IN COMPARISON WITH INSULIN GLARGINE U100 IN THE TREATMENT OF TYPE 1 DIABETES MELLITUS IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM

Value in Health ◽

10.1016/j.jval.2016.03.1285 ◽

2016 ◽

Vol 19 (3) ◽

pp. A200

Author(s):

A.D. Piedade ◽

L. Paladini ◽

J.S. Alves ◽

T.d. Gonçalves ◽

F. Griciunas

Keyword(s):

Diabetes Mellitus ◽

Health Care ◽

Type 1 Diabetes ◽

Cost Analysis ◽

Insulin Glargine ◽

Health Care System ◽

Insulin Degludec ◽

Private Health Care

Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine for Patients with Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom

Value in Health ◽

10.1016/j.jval.2013.08.686 ◽

2013 ◽

Vol 16 (7) ◽

pp. A442

Author(s):

M. Evans ◽

B. Chubb ◽

T. Christensen ◽

J. Gundgaard ◽

M. Wolden

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

United Kingdom ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Insulin Therapy ◽

Insulin Degludec ◽

The United Kingdom

Continuous Glucose Monitoring During Basal–Bolus Therapy Using Insulin Glargine 300 U mL−1 and Glargine 100 U mL−1 in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study

Diabetes Therapy ◽

10.1007/s13300-015-0115-1 ◽

2015 ◽

Vol 6 (2) ◽

pp. 143-152 ◽

Cited By ~ 12

Author(s):

Hideaki Jinnouchi ◽

Masayoshi Koyama ◽

Atsushi Amano ◽

Yoshinori Takahashi ◽

Akira Yoshida ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Pilot Study ◽

Insulin Glargine ◽

Continuous Glucose Monitoring ◽

Glucose Monitoring ◽

Japanese People ◽

Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen

Terapevticheskii arkhiv ◽

10.17116/terarkh2015871042-49 ◽

2015 ◽

Vol 87 (10) ◽

pp. 42

Author(s):

N. V. Efremova ◽

L. L. Bolotskaya ◽

D. S. Atarshchikov ◽

O. N. Bondarenko ◽

A. V. Ilyin ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Young Patients ◽

Insulin Analogues ◽

Insulin Glulisine ◽

Basal Bolus ◽

Observational Program

The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies

The European Journal of Health Economics ◽

10.1007/s10198-012-0433-4 ◽

2012 ◽

Vol 14 (6) ◽

pp. 887-899 ◽

Cited By ~ 4

Author(s):

Jen Kruger ◽

Alan Brennan

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

United Kingdom ◽

Cost Of Illness ◽

The United Kingdom ◽

The Cost ◽

Cost Of Illness Studies

936-P: Annual Cost to Achieve Cost Effectiveness of Continuous Glucose Monitoring in Hypoglycemia-Unaware Type 1 Diabetes Patients Using Intensive Insulin in the United Kingdom

Diabetes ◽

10.2337/db19-936-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 936-P

Author(s):

S. PINAR BILIR ◽

CARESSE CAMPBELL ◽

RICHARD HELLMUND ◽

JULIE MUNAKATA

Keyword(s):

Type 1 Diabetes ◽

United Kingdom ◽

Cost Effectiveness ◽

Continuous Glucose Monitoring ◽

Annual Cost ◽

Glucose Monitoring ◽

The United Kingdom ◽

Diabetes Patients